For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210416:nBw6x406la&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 15 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,686,942 1.31% 163,372 0.13%
(2) Derivatives (other than options):
72,359 0.06% 7,100 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,765,401 1.37% 176,572 0.14%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 237.1800 USD
Purchase 2 238.2700 USD
Purchase 3 239.0166 USD
Purchase 86 238.2775 USD
Purchase 100 237.9300 USD
Purchase 100 238.8300 USD
Purchase 100 238.5200 USD
Purchase 101 238.3200 USD
Purchase 121 238.7729 USD
Purchase 180 237.9311 USD
Purchase 300 238.1033 USD
Purchase 300 237.8900 USD
Purchase 600 237.9900 USD
Purchase 700 238.0485 USD
Purchase 700 238.4257 USD
Purchase 700 238.3010 USD
Purchase 800 238.0325 USD
Purchase 900 238.2822 USD
Purchase 1,133 238.0449 USD
Purchase 1,200 238.0312 USD
Purchase 1,361 238.2659 USD
Purchase 1,513 238.0399 USD
Purchase 1,910 237.7932 USD
Purchase 2,036 238.2175 USD
Purchase 2,700 238.2189 USD
Purchase 4,304 238.2028 USD
Purchase 4,518 238.1965 USD
Purchase 6,487 238.0373 USD
Purchase 7,018 237.9800 USD
Purchase 22,602 238.0878 USD
Sale 1 238.6500 USD
Sale 2 238.9600 USD
Sale 2 237.9850 USD
Sale 2 238.4450 USD
Sale 2 238.4150 USD
Sale 3 238.7466 USD
Sale 3 238.5616 USD
Sale 3 238.5483 USD
Sale 3 238.2633 USD
Sale 4 238.8850 USD
Sale 5 238.2880 USD
Sale 7 238.3485 USD
Sale 9 238.2611 USD
Sale 44 238.1219 USD
Sale 100 238.5500 USD
Sale 100 238.7900 USD
Sale 125 238.5593 USD
Sale 350 238.1695 USD
Sale 1,460 237.9800 USD
Sale 1,490 237.6707 USD
Sale 1,706 237.7038 USD
Sale 2,124 238.1555 USD
Sale 2,276 238.0400 USD
Sale 3,116 238.2479 USD
Sale 3,594 238.1656 USD
Sale 4,600 238.2170 USD
Sale 5,135 237.9798 USD
Sale 10,000 238.0272 USD
Sale 26,310 238.1467 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 16 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210416005254/en/
(https://www.businesswire.com/news/home/20210416005254/en/)
BARCLAYS PLC
Copyright Business Wire 2021